Table 1.
Preoperative characteristics of the three cases
| Case 1 | Case 2 | Case 3 | |
|---|---|---|---|
| Age (years)/Sex | 21/F | 28/F | 43/M |
| Tumor size and location |
19 mm in segment 2 36 mm in segment 4 |
80 mm in segment 6 30 mm in segment 7 |
23 mm in segment 3 |
| SpO2 (%) | 98 | 94 | 92 |
| SVEF (%) | 54 | 51 | 72 |
| CVP (mmHg) a | 12 | 20 | 18 |
| mPAP (mmHg) a | 11 | 17 | 14 |
| PVR (wood units) a | 1.3 | 1.6 | 1.5 |
| ScvO2 (%)a | 68 | 83 | 66 |
| CI (L/min/m2) a | 2.4 | 3.6 | 2.1 |
| Hb (g/dL) | 12.2 | 13.0 | 13.0 |
| Platelet count (103/µL) | 184 | 174 | 139 |
| PT-INR | 1.28 | 1.03 | 1.23 |
| APTT (s) | 58 | 32.7 | 59 |
| Child–Pugh classification | A | A | A |
| Antiplatelet drug | + | + | - |
| Anticoagulant drug | + | - | + |
| Heparin bridging | + | - | + |
aValues from cardiac catheterization are within one month prior to surgery
APTT Activated partial thromboplastin time, CI Cardiac index, CVP Central venous pressure, F Female, Hb Hemoglobin, INR International normalized ration of partial thrombin time, M male, mPAP mean pulmonary artery pressure, PVR pulmonary vascular resistance, SpO2 oxygen saturation, ScvO2 central venous blood oxygen saturation, SVEF systemic ventricular ejection fraction